EUVIMEDEUVIMED entdecken
Crossref

Effects of topical isoxsuprine ointment on imiquimod-induced psoriasiform skin inflammation in mice

Ahmed Wahhab Khafaji, Adeeb Ahmed Al-Zubaidy, Iqbal Ghalib Farhood, Hayder Adnan Fawzi iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03359-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Ahmed Wahhab Khafaji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq. Hauptthemen laut MEDLINE: Psoriasis, Skin, Anti-Inflammatory Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study assesses the potential positive impact of a 0.05% isoxsuprine ointment on psoriasiform skin inflammation generated by imiquimod in mouse models. Thirty-two male albino mice were allocated into four groups: the control group (which received topical emollients twice daily for 16 days), the induction group (which received imiquimod cream (5%) for 8 days, twice daily followed by petrolatum gel (15%) for another 8 days), and the other two groups, which received imiquimod cream (5%) for 8 days followed by either clobetasol ointment (0.05%) or isoxsuprine ointment (0.05%) twice daily for an additional 8 days. At the end of the experiment, mice were sacrificed by ethical standards, and levels of TNF-α, IL-6, IL-17A, IL-23, and VEGF were measured; PASI and Backer's score were examined, in addition to the histopathology of skin tissue. Each clobetasol and isoxsuprine group displayed a significant reduction in tissue homogenate levels of TNF-α, IL-6, IL-17A, IL-23, and VEGF, besides increments in IL-10 compared to the induction group. Some markers (IL-17A, IL23, and VEGF) showed no significant difference between clobetasol and the isoxsuprine group. In contrast, the other markers (TNF-α, IL6, and IL10) showed significant differences between clobetasol and isoxsuprine groups. Isoxsuprine ointment showed comparable efficacy to clobetasol ointment in treating imiquimod-induced psoriasiform skin inflammation in mice models, probably due to its possible effect of anti-inflammatory and immunomodulatory activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisSkinAnti-Inflammatory AgentsAnimalsImiquimodMaleOintmentsMiceCytokinesAdministration, TopicalDisease Models, Animal

Stichwörter der Autor:innen

ClobetasolImiquimodInterleukinIsoxsuprinePsoriasis

Substanzen

ImiquimodOintmentsAnti-Inflammatory AgentsCytokines

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq.
  • Department of Pharmacology, College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq.
  • Department of Medicine, College of Medicine, Al-Nahrain University, Baghdad, Iraq.
  • Department of Pharmacy, Al-Mustafa University College, Baghdad, Iraq. haider-pharm@almustafauniversity.edu.iq.

ORCID-Profile: Hayder Adnan Fawzi

Zitieren

APA

Khafaji, A. W., Al-Zubaidy, A. A., Farhood, I. G., & Fawzi, H. A. (2025). Effects of topical isoxsuprine ointment on imiquimod-induced psoriasiform skin inflammation in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03359-2

Vancouver

Khafaji AW, Al-Zubaidy AA, Farhood IG, Fawzi HA. Effects of topical isoxsuprine ointment on imiquimod-induced psoriasiform skin inflammation in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03359-2

BibTeX
@article{Khafaji2025,
  author = {Khafaji, Ahmed Wahhab and Al-Zubaidy, Adeeb Ahmed and Farhood, Iqbal Ghalib and Fawzi, Hayder Adnan},
  title = {Effects of topical isoxsuprine ointment on imiquimod-induced psoriasiform skin inflammation in mice},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03359-2}
}
Kostenlos starten →